Veeva Systems Inc: Form 10-K for the period ended Jan 31, 2022
Filed with the SEC on Mar 30, 2022 and accepted by EDGAR at Mar 30, 2022, 21:08 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-02-01 to 2022-01-31 | $1.85bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2021-02-01 to 2022-01-31 | $503.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2021-02-01 to 2022-01-31 | $1.35bn | us-gaap:GrossProfit |
| Research and development | 12 months2021-02-01 to 2022-01-31 | $382.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2021-02-01 to 2022-01-31 | $505.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2021-02-01 to 2022-01-31 | $84.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-02-01 to 2022-01-31 | $427.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-02-01 to 2022-01-31 | $2.63 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-02-01 to 2022-01-31 | $2.79 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-02-01 to 2022-01-31 | 162,277,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-02-01 to 2022-01-31 | $764.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2022-01-31 | $1.14bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-01-31 | $3.11bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-01-31 | $3.82bn | us-gaap:Assets |
| Current liabilities | At period end2022-01-31 | $840.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-01-31 | $904.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-01-31 | $2.91bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001393052-22-000017. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.